(NASDAQ:CDXS), Announces revenue of $15.3M vs $14.1M analyst consensus estimate Six presentations featured ECO Synthesis(R) platform at 2025 TIDES USA annual meeting, including three from leading CDMO collaborators $27.3M raised via ATM facility and Innovatus loan to support expansion of ECO Synthesis REDWOOD CITY, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), […]
(NASDAQ:XPON), Q2 2025 Sales Growth of 134% to $3.0 Million Fueled by Strong Demand for New Products and Technologies Records Two of the Most Successful Months of Sales in Company History in Q2 2025 Sixth Consecutive Quarter of Sales Growth REDMOND, Ore., Aug. 13, 2025 (GLOBE NEWSWIRE) — Expion360 Inc. (Nasdaq: XPON) (“Expion360” or the
dLocal Reports 2025 Second Quarter Financial Results GlobeNewswire August 13, 2025 TPV at record high of US$9.2 billion, growing more than 50% YoY for the third consecutive quarter.Brazil and Mexico posted solid results, while growth remains fastest in the rest of our geographies, leading to increased diversification.Consistent operational leverage with Adjusted EBITDA over Gross Profit
(NASDAQ:LGVN),(NASDAQ:LGVNR), Full enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indication ELPIS II top-line trial results are anticipated in the third quarter of 2026, after the final follow-up at 12-months Laromestrocel Biological License Application (BLA) submission for full
AirJoule Technologies Announces Second Quarter 2025 Results GlobeNewswire August 13, 2025 RONAN, Mont., Aug. 13, 2025 (GLOBE NEWSWIRE) — AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), a leading technology platform that unleashes the power of water from air, today announced its second quarter 2025 results. Second Quarter 2025 & Recent Highlights Key
(NASDAQ:JBIO), Presented preclinical data for JADE101 at the 62nd European Renal Association Congress, highlighting its potential as a best-in-class anti-APRIL monoclonal antibody for IgA nephropathy Phase 1 healthy-volunteer study of JADE101 expected to begin in the third quarter of 2025, with interim, biomarker-rich data anticipated in the first half of 2026 $220.9 million cash and
Five Below, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call Date GlobeNewswire August 13, 2025 PHILADELPHIA, PA, Aug. 13, 2025 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality, extreme-value retailer for tweens, teens and beyond, today announced that its financial results for the second quarter of fiscal 2025 will be
Glass House Brands Reports Second Quarter 2025 Financial Results GlobeNewswire August 13, 2025 Results surpassed expectations across key metrics including biomass production, revenue, gross profit, and Adjusted EBITDA Wholesale biomass production was 230,748 pounds, up 54% year-over-year Cost of production was $91 per pound, a substantial improvement compared to $148 per pound in Q2 2024
(NASDAQ:AQMS), RENO, Nev., Aug. 13, 2025 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), a pioneer in sustainable metals recycling, today announced financial results and operational highlights for the quarter ended June 30, 2025. The Company achieved significant progress toward commercialization, delivering best-in-class product quality, advancing key strategic initiatives, and
(NASDAQ:HOOD), MENLO PARK, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) — Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for July 2025. Funded Customers at the end of July were 26.7 million (up about 160 thousand from June 2025, up approximately 2.5 million year-over-year). Total Platform Assets at the end of July